LIDOCAINE HYDROCHLORIDE AND DEXTROSE

Product NDC: 51662-1657
11-digit product format: 516621657
Labeler code: 51662
Product ID: 51662-1657_48d89045-e9f9-b84c-e063-6394a90a28a3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LIDOCAINE HYDROCHLORIDE AND DEXTROSE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Application: NDA018461
Marketing category: NDA
Marketing start: 1981-04-22
Substance: LIDOCAINE HYDROCHLORIDE
Active strength: 8 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982
N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982
N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982
N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N018461-002	AP
N018461-003	AP
N018461-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018461-001	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	100MG/100ML	INJECTABLE / INJECTION		Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018461-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018461-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018461-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP		1982-02-22	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018461-003	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018461-004	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018461-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018461-003	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018461-004	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018461-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018461-003	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018461-004	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018461-002	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018461-003	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018461-004	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018461-002	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018461-003	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018461-004	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018461-002	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018461-003	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018461-004	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018461-002	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018461-003	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018461-004	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018461-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018461-003	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018461-004	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018461-002	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018461-003	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018461-004	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018461-002	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018461-003	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018461-004	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018461-002	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018461-003	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018461-004	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018461-002	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018461-003	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018461-004	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018461-002	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018461-003	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018461-004	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018461-002	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018461-003	AP	1	`c0c555d07b60…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: LIDOCAINE HYDROCHLORIDE AND DEXTROSE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LIDOCAINE HYDROCHLORIDE	8 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
V13007Z41A	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1737723	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1bf999b5-e290-dcbd-e063-6294a90a2bab	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51662-1657-1	LIDOCAINE HYDROCHLORIDE AND DEXTROSE	250 mL in 1 BAG	INJECTION, SOLUTION	250		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51662-1657	LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]	1	Current NDC, 1 package rows	20240716_1bf999b5-e290-dcbd-e063-6294a90a2bab.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Hydrochloride and Dextrose	LIDOCAINE HYDROCHLORIDE	Baxter Healthcare Corporation	f21512ea-c7c3-4766-b976-b2c0b5616bf0	2026-02-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018461 application number: NDA018461
LIDOCAINE HYDROCHLORIDE AND DEXTROSE	LIDOCAINE HYDROCHLORIDE AND DEXTROSE	HF Acquisition Co LLC, DBA HealthFirst	1bf999b5-e290-dcbd-e063-6294a90a2bab	2026-01-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018461 application number: NDA018461 ndc (product): 51662-1657

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V13007Z41A	LIDOCAINE HYDROCHLORIDE	6108-05-0	LIDOCAINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1737723	lidocaine HCl 0.8 % in 250 ML Injection	PSN	1bf999b5-e290-dcbd-e063-6294a90a2bab	2
1737723	250 ML lidocaine hydrochloride 8 MG/ML Injection	SCD	1bf999b5-e290-dcbd-e063-6294a90a2bab	2
1737723	lidocaine HCl 0.8 % per 250 ML Injection	SY	1bf999b5-e290-dcbd-e063-6294a90a2bab	2
1737723	lidocaine HCl 2 GM per 250 ML Injection	SY	1bf999b5-e290-dcbd-e063-6294a90a2bab	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
51662-1657-1	51662165701	250 mL in 1 BAG (51662-1657-1)	250 ml	1981-04-22	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LIDOCAINE HYDROCHLORIDE AND DEXTROSE - HF Acquisition Co LLC, DBA HealthFirst	HF Acquisition Co LLC, DBA HealthFirst	2026-01-20	HUMAN PRESCRIPTION DRUG LABEL	2